DI CESARE MANNELLI, LORENZO
 Distribuzione geografica
Continente #
NA - Nord America 27.953
EU - Europa 24.494
AS - Asia 11.893
SA - Sud America 2.109
Continente sconosciuto - Info sul continente non disponibili 649
AF - Africa 341
OC - Oceania 165
Totale 67.604
Nazione #
US - Stati Uniti d'America 27.369
PL - Polonia 10.512
RU - Federazione Russa 5.350
IT - Italia 4.014
SG - Singapore 3.162
CN - Cina 2.697
HK - Hong Kong 1.896
BR - Brasile 1.695
VN - Vietnam 1.464
IE - Irlanda 1.278
KR - Corea 894
SE - Svezia 852
FI - Finlandia 580
FR - Francia 510
DE - Germania 448
IN - India 401
GB - Regno Unito 368
CA - Canada 362
ID - Indonesia 282
BD - Bangladesh 273
AR - Argentina 161
JP - Giappone 156
AU - Australia 155
JO - Giordania 141
UA - Ucraina 120
NL - Olanda 100
TR - Turchia 93
IQ - Iraq 89
MX - Messico 88
CI - Costa d'Avorio 85
ES - Italia 83
ZA - Sudafrica 69
EC - Ecuador 64
CH - Svizzera 59
BE - Belgio 53
CO - Colombia 51
PK - Pakistan 42
NG - Nigeria 36
MA - Marocco 35
VE - Venezuela 33
PY - Paraguay 32
SA - Arabia Saudita 32
RO - Romania 28
UZ - Uzbekistan 28
PE - Perù 27
AE - Emirati Arabi Uniti 26
JM - Giamaica 26
CL - Cile 25
EG - Egitto 23
PH - Filippine 23
TH - Thailandia 23
IR - Iran 22
TN - Tunisia 22
MY - Malesia 20
CR - Costa Rica 19
IL - Israele 18
AZ - Azerbaigian 16
AL - Albania 15
HN - Honduras 15
DZ - Algeria 14
AT - Austria 13
LB - Libano 13
PT - Portogallo 13
KE - Kenya 12
BG - Bulgaria 11
KZ - Kazakistan 11
LT - Lituania 11
NP - Nepal 11
TW - Taiwan 11
CZ - Repubblica Ceca 10
BO - Bolivia 9
DO - Repubblica Dominicana 9
GT - Guatemala 9
NZ - Nuova Zelanda 9
SK - Slovacchia (Repubblica Slovacca) 9
SV - El Salvador 9
UY - Uruguay 9
BJ - Benin 8
NI - Nicaragua 8
TT - Trinidad e Tobago 8
DK - Danimarca 7
ET - Etiopia 7
PR - Porto Rico 7
SN - Senegal 7
EE - Estonia 6
GR - Grecia 6
KG - Kirghizistan 6
LV - Lettonia 6
QA - Qatar 6
RS - Serbia 6
BB - Barbados 5
BH - Bahrain 5
NO - Norvegia 5
OM - Oman 5
AM - Armenia 4
CG - Congo 4
HR - Croazia 4
HU - Ungheria 4
KW - Kuwait 4
PS - Palestinian Territory 4
Totale 66.885
Città #
Warsaw 10.500
Santa Clara 5.194
Ashburn 3.569
Singapore 2.217
Fairfield 2.212
Hong Kong 1.609
Dublin 1.267
San Jose 1.246
Woodbridge 1.032
Chandler 1.010
Seattle 907
Seoul 864
Cambridge 829
Houston 798
Wilmington 739
Milan 692
Council Bluffs 682
Beijing 632
Florence 552
Altamura 436
Lawrence 430
Ho Chi Minh City 423
Ann Arbor 406
Hefei 387
The Dalles 373
Los Angeles 372
Princeton 363
Rome 352
Helsinki 305
Lauterbourg 300
Hanoi 289
Buffalo 278
Moscow 277
New York 237
Dallas 223
Mumbai 221
Jakarta 206
Phoenix 206
Dong Ket 198
Boston 196
Medford 193
San Diego 160
Munich 152
Boardman 148
Jacksonville 145
Shanghai 143
Melbourne 139
Clifton 133
São Paulo 131
Tokyo 127
Chicago 111
Paris 109
Kent 108
London 86
Abidjan 85
Naples 85
Turin 80
Orem 79
Toronto 79
Frankfurt am Main 78
Philadelphia 76
Falls Church 75
Bologna 71
Turku 67
Redondo Beach 62
Guangzhou 59
Figino 57
Rio de Janeiro 57
Norwalk 55
Da Nang 53
Montreal 53
Tianjin 53
Haiphong 52
Brooklyn 51
Miano 50
Lappeenranta 49
Brussels 42
Bern 40
San Francisco 40
Chennai 38
Hillsboro 38
Palermo 38
Barcelona 37
Brasília 37
Baghdad 36
Bari 35
Genoa 35
Siena 35
Atlanta 33
Denver 31
Amsterdam 30
Biên Hòa 30
Izmir 28
North Bergen 28
Redwood City 28
Salt Lake City 28
Abuja 27
Curitiba 27
Venice 26
Amman 25
Totale 47.132
Nome #
AG-4:A NICOTINIC AGONIST ENDOWED WITH ANTIAMNESIC PROPERTIES 406
Acute effect of Capparis spinosa root extracts on rat articular pain 395
A novel manganese complex effective as superoxide anion scavenger and therapeutic agent against cell and tissue oxidative injury. 387
Effect of the SOD mimetic MnL4 on in vitro and in vivo oxaliplatin toxicity: Possible aid in chemotherapy induced neuropathy 378
Astragali radix: could it be an adjuvant for oxaliplatin-induced neuropathy? 370
Oxaliplatin Neurotoxicity Involves Peroxisome Alterations. PPARc Agonism as Preventive Pharmacological Approach 367
Synthesis of novel cognition enhancer with pyrazolo[5,1-c][1,2,4]benzotriazine core acting at gamma-aminobutyric acid type A (GABAA) receptor. 363
Local anaesthetic activity of beta-caryophyllene. 360
Gc-protein derived macrophage activating factor (GcMAF) counteracts the neuronal damage induced by oxaliplatin 358
Atomoxetine for hoarding disorder: A pre-clinical and clinical investigation 358
α7 Nicotinic Receptor Promotes the Neuroprotective Functions of Astrocytes against Oxaliplatin Neurotoxicity 358
LOCAL ANAESTHETIC ACTIVITY OF (+) AND (-) MENTHOL 353
Aminopyrrolic synthetic receptors for monosaccharides: A class of carbohydrate-binding agents endowed with antibiotic activity versus pathogenic yeasts 350
Bacopa monnieri as augmentation therapy in the treatment of anhedonia, preclinical and clinical evaluation 350
Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats 343
Anti-neuropathic effects of Rosmarinus officinalis L. terpenoid fraction: Relevance of nicotinic receptors 340
Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicity 338
Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy 338
Erucin exhibits vasorelaxing effects and antihypertensive activity by H2 S-releasing properties 337
Delay of morphine tolerance by palmitoylethanolamide 336
Apoptotic Process Induced by Oxaliplatin in Rat Hippocampus Causes Memory Impairment 333
BDNF and ARTEMIN are increased in drug-naïve non-depressed GAD patients: Preliminary data 329
Involvement of the N/OFQ-NOP system in rat morphine antinociceptive tolerance: Are astrocytes the crossroad? 329
The pharmacological basis of opioids 329
ANTINOCICEPTIVE PROFILE OF THE NATURAL CHOLINESTERASE INHIBITOR HUPERZINE A 328
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 325
Adipose-derived stem cells decrease pain in a rat model of oxaliplatin-induced neuropathy: Role of VEGF-A modulation 324
The novel H2S-donor 4-carboxyphenyl isothiocyanate promotes cardioprotective effects against ischemia/reperfusion injury through activation of mitoKATP channels and reduction of oxidative stress 324
The Role of TRPA1 and TRPV1 Channels in Orofacial Pain 323
Improving the therapeutic efficacy of prilocaine by PLGA microparticles: Preparation, characterization and in vivo evaluation. 322
Acute visceral pain relief mediated by A(3)AR agonists in rats: involvement of N-type voltage-gated calcium channels 320
Selenium and zinc: Two key players against cadmium-induced neuronal toxicity. 314
A rat model of FOLFOX-induced neuropathy: effects of oral dimiracetam in comparison with duloxetine and pregabalin 312
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 310
Effects of Hypericum perforatum extract on oxaliplatin-induced neurotoxicity: in vitro evaluations 308
Identification of a new pyrazolo[1,5-a]quinazoline ligand highly affine to γ-aminobutyric type A (GABAA) receptor subtype with anxiolytic-like and antihyperalgesic activity 307
Palmitoylthanolamide is a disease-modifying agent in peripheral neuropathy: pain relief and neuroprotection share a PPAR-apha-mediated mechanism. 306
Combined Approach of Cyclodextrin Complexation and Nanostructured Lipid Carriers for the Development of a Pediatric Liquid Oral Dosage Form of Hydrochlorothiazide 305
A Series of COX-2 Inhibitors Endowed with NO-Releasing Properties: Synthesis, Biological Evaluation, and Docking Analysis 304
Different apoptotic pathways activated by oxaliplatin in primary astrocytes vs. colo-rectal cancer cells 303
Design, Synthesis, and Biological Evaluation of Imidazo[1,5-a]quinoline as Highly Potent Ligands of Central Benzodiazepine Receptors 302
Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin 299
Effect of treatment with the antioxidant alpha-lipoic (thioctic) acid on heart and kidney microvasculature in spontaneously hypertensive rats 299
Selective HCN1 block as a strategy to control oxaliplatin-induced neuropathy 299
Astragalus membranaceus and oxaliplatin-induced neuropathy: pain relief and prevention of nervous tissue modifications. 296
Development of solid lipid nanoparticles as carriers for improving oral bioavailability of glibenclamide 295
ANTIAMNESIC EFFECT OF THE TWO NOVEL K-OPIOID AGONISTS, VA-100 AND VA-101, IN THE MOUSE PASSIVE AVOIDANCE TEST 294
Brain activity of thioctic Acid enantiomers: in vitro and in vivo studies in an animal model of cerebrovascular injury 293
Therapeutic Effects of the Superoxide Dismutase Mimetic Compound Mn(II)Me2DO2A on Experimental Articular Pain in Rats. 292
Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain 292
Synthesis and Biological Evaluation of Novel Neuroprotective Pyridazine Derivatives as Excitatory Amino Acid Transporter 2 (EAAT2) Activators 292
Low dose native type II collagen prevents pain in a rat osteoarthritis model 291
Synthesis and biological evaluation of fluorinated 1,5-diarylpyrrole-3-alkoxyethyl ether derivatives as selective COX-2 inhibitors endowed with anti-inflammatory activity 291
Pretreatment with Relaxin Does Not Restore NO-Mediated Modulation of Calcium Signal in Coronary Endothelial Cells Isolated from Spontaneously Hypertensive Rats 288
α2 Adrenoceptor: a Target for Neuropathic Pain Treatment 287
PPAR-γ Impairment Alters Peroxisome Functionality in Primary Astrocyte Cell Cultures 286
Neuropathy-induced apoptosis: Protective effect of physostigmine 286
Effects of a water extract of Lepidium meyenii root in different models of persistent pain in rats 285
Neuroprotective activity of thioctic acid in central nervous system lesions consequent to peripheral nerve injury. 285
Photobiomodulation therapy by NIR laser in persistent pain: an analytical study in the rat 284
Calcium alginate microspheres containing metformin hydrochloride niosomes and chitosomes aimed for oral therapy of type 2 diabetes mellitus 284
Pretreatment with relaxin does not restore no-mediated modulation of calcium signal in coronary endothelial cells isolated from spontaneously hypertensive rats 283
Analgesic and antineuropathic drugs acting through central cholinergic mechanisms 283
RELAXANT EFFECT OF A WATER SOLUBLE CARBON MONOXIDE-RELEASING MOLECULE (CORM-3) ON SPONTANEOUSLY HYPERTENSIVE RAT AORTAS 277
Using palmitoylethanolamide in combination with opioids 277
OXALIPLATIN-INDUCED BLOOD BRAIN BARRIER LOOSENING: A NEW POINT OF VIEW ON CHEMOTHERAPY-INDUCED NEUROTOXICITY 274
Synthesis, antiarrhythmic activity, and toxicological evaluation of mexiletine analogues 273
Heterocoumarins Are Selective Carbonic Anhydrase IX and XII Inhibitors with Cytotoxic Effects against Cancer Cells Lines 272
4-Hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms IX and XII showing hypoxia-enhanced anti-proliferative profiles. 271
Development of ligands at gamma aminobutyrric acid type A (GABAA) receptor subtype as new agent for pain relief. 271
GLUTAMATERGIC SYSTEM MODULATORS AS AGENTS IN PREVENTION AND MANAGEMENT OF CHEMOTHERAPY- INDUCED POLYNEUROPATHY 270
TREATMENT WITH ACETYL-L-CARNITINE EXERTS A NEUROPROTECTIVE EFFECT IN THE SCIATIC NERVE FOLLOWING LOOSE LIGATION: A FUNCTIONAL AND MICROANATOMICAL STUDY 269
Synthesis, biological evaluation and docking analysis of a new series of methylsulfonyl and sulfamoyl acetamides and ethyl acetates as potent COX-2 inhibitors 267
Effects of Cadmium on ZO-1 Tight Junction Integrity of the Blood Brain Barrier. 265
Visceral sensitivity modulation by faecal microbiota transplantation: the active role of gut bacteria in pain persistence 264
Tanshinones from Salvia miltiorrhiza Bunge revert chemotherapy-induced neuropathic pain and reduce glioblastoma cells malignancy 263
Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors 262
Synthesis of five and six-membered heterocycles bearing an arylpiperazinylalkyl side chain as orally active antinociceptive agents 261
Pain relieving and protective effects of Astragalus hydroalcoholic extract in rat arthritis models 257
Anticancer properties of erucin, an H2 S-releasing isothiocyanate, on human pancreatic adenocarcinoma cells (AsPC-1). 257
Effect of glucoraphanin and sulforaphane against chemotherapy-induced neuropathic pain: Kv7 potassium channels modulation by H2 S release in vivo. 257
Effects of natural and synthetic isothiocyanate-based H2S-releasers against chemotherapy-induced neuropathic pain: Role of Kv7 potassium channels 256
New Rigid Nicotine Analogues, Carrying a Norbornane Moiety, Are Potent Agonists of α7 and α3∗ Nicotinic Receptors 252
Intestinal inflammation increases convulsant activity and reduces antiepileptic drug efficacy in a mouse model of epilepsy. 250
Synthesis and pharmacological evaluation of novel GABAA subtype receptor ligands with potential anxiolytic-like and anti-hyperlagesic effect 246
Lipoyl-Homotaurine Derivative (ADM_12) Reverts Oxaliplatin-Induced Neuropathy and Reduces Cancer Cells Malignancy by Inhibiting Carbonic Anhydrase IX (CAIX) 244
Coronaridine congeners decrease neuropathic pain in mice and inhibit α9α10 nicotinic acetylcholine receptors and CaV2.2 channels 243
Cannabidiol protects dopaminergic neuronal cells from cadmium 241
Prophylactic versus Therapeutic Fingolimod: Restoration of Presynaptic Defects in Mice Suffering from Experimental Autoimmune Encephalomyelitis 240
Synergic stimulation of serotonin 5-HT1A receptor and α2-adrenoceptors for neuropathic pain relief: Preclinical effects of 2-substituted imidazoline derivatives 239
Blueberry juice protects osteocytes and bone precursor cells against oxidative stress partly through SIRT1 238
Structural investigations on coumarins leading to chromeno[4,3-c]pyrazol-4-ones and pyrano[4,3-c]pyrazol-4-ones: New scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII 238
Design, Synthesis, and X-ray of Selenides as New Class of Agents for Prevention of Diabetic Cerebrovascular Pathology 237
Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain 236
Phaseolus vulgaris L. Extract: Alpha-Amylase Inhibition against Metabolic Syndrome in Mice . 236
Selective Blockade of HCN1/HCN2 Channels as a Potential Pharmacological Strategy Against Pain 235
3-Hydroxy-1H-quinazoline-2,4-dione as a New Scaffold to Develop Potent and Selective Inhibitors of the Tumor-Associated Carbonic Anhydrases IX and XII 233
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino Derivatives As New Potent and Selective Human A3Adenosine Receptor Antagonists. Molecular Modeling Studies and Pharmacological Evaluation 232
Identification of the First Synthetic Allosteric Modulator of the CB2 Receptors and Evidence of Its Efficacy for Neuropathic Pain Relief 231
Development of Potent Inhibitors of Fatty Acid Amide Hydrolase Useful for the Treatment of Neuropathic Pain 230
Totale 29.590
Categoria #
all - tutte 180.860
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 180.860


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.132 0 0 210 117 74 144 91 187 188 189 310 622
2022/20235.305 540 1.178 254 264 334 929 768 287 469 38 153 91
2023/20242.021 90 218 349 97 138 281 97 355 51 137 138 70
2024/202515.786 527 1.696 1.090 2.242 4.320 2.024 468 820 925 450 613 611
2025/202619.688 1.812 2.317 1.455 2.012 1.917 814 2.149 1.045 1.504 1.303 803 2.557
2026/20272.780 920 641 1.219 0 0 0 0 0 0 0 0 0
Totale 67.604